SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101’

B SEONGNAM, South Korea, May 14, 2026 /PRNewswire/ — SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated…
posteditor
posteditor
Articles: 21727

Other News